Daojun Mo

机构：Eli Lilly (United States) · ORCID：0000-0002-9080-9713

发表论文 24 篇 · 总被引 789 次 · h-index 12

代表论文

Obesity and glycemic control in patients with diabetes mellitus: Analysis of physician electronic health records in the US from 2009–2011 (2015 · Journal of Diabetes and its Complications · 被引 137)
Prevalence of Metabolic Syndrome in Adult Hypopituitary Growth Hormone (GH)-Deficient Patients Before and After GH Replacement (2009 · The Journal of Clinical Endocrinology & Metabolism · 被引 115)
Safety profile of baricitinib for the treatment of rheumatoid arthritis over a median of 3 years of treatment: an updated integrated safety analysis (2020 · The Lancet Rheumatology · 被引 83)
Prevalence and Incidence of Diabetes Mellitus in Adult Patients on Growth Hormone Replacement for Growth Hormone Deficiency: A Surveillance Database Analysis (2011 · The Journal of Clinical Endocrinology & Metabolism · 被引 74)
Metabolic, Cardiovascular, and Cerebrovascular Outcomes in Growth Hormone-Deficient Subjects with Previous Cushing’s Disease or Non-Functioning Pituitary Adenoma (2009 · The Journal of Clinical Endocrinology & Metabolism · 被引 65)
Fracture risk in adult patients treated with growth hormone replacement therapy for growth hormone deficiency: a prospective observational cohort study (2015 · The Lancet Diabetes & Endocrinology · 被引 62)